U.S. market Closed. Opens in 31 minutes

NRSNW | NeuroSense Therapeutics Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue97.00K89.00K3.00K3.00KN/A
Gross Profit-97.00K-89.00K-3.00K-3.00KN/A
Operating Expenses10.29M13.55M5.59M2.89M1.24M
Selling, General & Admin4.78M7.14M2.50M393.00K337.00K
Research & Development7.27M6.42M3.08M2.50M898.00K
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-12.05M-13.55M-5.59M-2.89M-1.24M
Other Expenses / Income1.94M1.21M1.55M60.00K13.00K
Before Tax Income-10.11M-12.34M-4.04M-2.83M-1.22M
Income Tax Expenses-1.00-1.14M-1.55M1.00K5.00K
Net Income-10.11M-11.20M-2.50M-2.83M-1.23M
Interest Expenses550.00K15.00K1.15M1.00K5.00K
Basic Shares Outstanding13.64M11.50M1.94M1.94M1.94M
Diluted Shares Outstanding13.64M11.50M1.94M1.94M1.94M
EBITDA-12.03M-13.38M-8.28M-2.82M-1.25M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-9.56M-12.32M-2.89M-2.83M-1.22M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙